Simvastatin EP Impurity A is a sodium salt derived from the hydrolysis of the lactone ring of Simvastatin, featuring a substituted dihydroxytetralin moiety linked to a carboxylate group. The compound retains the core 2-(4-hydroxyphenyl)-2-(methyl)-1-(methyl)pentyl structure of Simvastatin but exhibits an open-ring configuration with a sodium-bound carboxylate. This impurity arises during Simvastatin synthesis or degradation via hydrolytic cleavage of the lactone. It serves as an HPLC reference standard for quantifying process-related impurities in Simvastatin drug substances.
On RequestCCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)[O-])O)O)C.[Na+]
InChI=1S/C25H40O6.Na/c1-6-25(4,5)24(30)31-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-18(26)13-19(27)14-22(28)29;/h7-8,11,15-16,18-21,23,26-27H,6,9-10,12-14H2,1-5H3,(H,28,29);/q;+1/p-1/t15-,16-,18+,19+,20-,21-,23-;/m0./s1
RLWRROYWKHUVKF-OKDJMAGBSA-M